Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens.
Zhao J, Cochrane CS, Najeeb J, Gooden D, Sciandra C, Fan P, Lemaitre N, Newns K, Nicholas RA, Guan Z, Thaden JT, Fowler VG Jr, Spasojevic I, Sebbane F, Toone EJ, Duncan C, Gammans R, Zhou P.
Zhao J, et al. Among authors: cochrane cs.
Sci Transl Med. 2023 Aug 9;15(708):eadf5668. doi: 10.1126/scitranslmed.adf5668. Epub 2023 Aug 9.
Sci Transl Med. 2023.
PMID: 37556556
Free PMC article.